SEC Form D filing
Tinos Therapeutics, Inc., 2025-09-26
An SEC Form D private-offering notice from Cambridge, MA, a $4,000,000 filer-stated offering target in Biotech. Filed 2025-09-26. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Tinos Therapeutics, Inc. Verified via SEC Form D
Filed 2025-09-26Filed to raise $4,000,000First money in 2025-09-04Raised so far $2,250,000HQ (as filed) Cambridge, MASector Biotech machine-classified from the filing aloneStage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Crossbow Therapeutics, Inc., 2025-09-30, $80M, Cambridge, MA
- Ansa Biotechnologies, Inc., 2025-10-02, $56.9M, Emeryville, CA
- Element3 Health, Inc., 2025-09-29, $5M, Boston, MA
- Kilele Health Inc., 2025-10-01, $2M, Oakwood, OH
- Wasabi Holding, Inc., 2025-09-29, $70M, Boston, MA
- Lexaria Bioscience Corp., 2025-10-01, $4M, Kelowna, BC, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.